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Abstract: The human SFRS9/SRp30c belongs to the SR family of splicing 
regulators. Despite evidence that members of this protein family may be targeted 
by arginine methylation, this has yet to be experimentally addressed. In this 
study, we found that SFRS9 is a target for PRMT1-mediated arginine 
methylation in vitro, and that it is immunoprecipitated from HEK-293 lysates by 
antibodies that recognize both mono- and dimethylated arginines. We further 
observed that upon treatment with the methylation inhibitor Adox, the 
fluorescent EGFP-SFRS9 re-localizes to dot-like structures in the cell nucleus. 
In subsequent confocal analyses, we found that EGFP-SFRS9 localizes to 
nucleoli in Adox-treated cells. Our findings indicate the importance of arginine 
methylation for the subnuclear localization of SFRS9.  
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The process of pre-mRNA splicing is an essential step in controlling the 
expression of most eukaryotic genes. This RNA processing activity takes place 
in the spliceosomes, which are large ribonucleoprotein complexes formed by the 
small nuclear ribonucleoprotein particles (U1, U2, U4/U6 and U5 snRNPs) and 
several regulatory non-snRNP splicing factors [1]. The functionally and 
structurally highly conserved serine- and arginine-rich proteins (SR proteins) are 
non-snRNP splicing factors that may affect both constitutive and alternative 
splicing. They may function in the early stages of spliceosome assembly, during 
the recruitment of U1 snRNP and U2AF to the 5’ and 3’ splice sites [2], and in 
the later steps of the splicing reaction, when they facilitate the formation of the 
U4/U6.U5 trimer snRNP complex. They may also be involved in the first 
catalytic steps of the splicing itself [3]. 
The SR proteins have a modular domain structure consisting of one or two 
RNA-binding domains (RRM) and a C-terminal region rich in arginine/serine, 
the RS-rich domain [1, 4]. While RRMs determine RNA-binding specificity, the 
RS-rich domain mediates protein-protein interactions with other splicing factors, 
with the spliceosome, and also with different sequences within the pre-mRNA 
[4]. It has been reported that SR proteins are phosphorylated at serine residues 
within the RS domains, and that this modification can have a profound impact 
on their activity [1, 4]. Although several SR proteins have been identified as part 
of protein complexes related to arginine methylation activity [5], to date, no 
study has experimentally assessed this post-translational modification for these 
proteins. Arginine methylation occurs frequently in the context of 
RGG/RXR/RG motifs (RG-rich) and is catalyzed by a class of proteins called 
arginine methyl transferases (PRMTs). The methylation of these RG-rich 
clusters commonly occurs in RNA-binding proteins, and it has been implicated 
to be important for several cellular processes, such as subcellular localization, 
transcription, signal transduction and mRNA processing, including splicing [6]. 
We examined the arginine methylation of the SR protein SFRS9/SRp30c and the 
effects of inhibiting the methylation process on the nuclear distribution of 
EGFP-SFRS9 in cultured cells. Our study yielded new data concerning the 
relevance of the arginine methylation modification for the function of SFRS9 
and other members of the SR protein family. 
 
MATERIALS AND METHODS 
 
Plasmids, recombinant proteins and in vitro methylation assays 
The full-length SFRS9 cDNA was amplified by PCR from a fetal brain cDNA 
library (Clontech) and cloned into the vector pEGFP-C2 (Invitrogen) and the 
baculovirus transfer vector pFastBac Hta (Invitrogen). The cloning of the full-
length FEZ1 cDNA into the pET 28a vector (Novagen/EMD Biosciences), and 
the protein expression and purification procedures were performed as previously 
described [28]. The recombinant PRMT1-pGEX-5X-2 has been described 




elsewhere [8]. The bacteria (GST-PRMT1 and 6xhisFEZ1) and baculovirus 
(6xHis-SFRS9) recombinant protein production and in vitro methylation assays 
were performed as previously described [8, 9]. 
 
Cell culture, transfection, treatments, Western blots and immunoprecipitations 
Human HEK-293 cells were cultured in Minimum Essential Medium (MEM) 
supplemented with 10% fetal bovine serum, 100 U/ml penicillin and 100 μg/ml 
streptomycin. Transient transfections were performed using the calcium 
phosphate method. The Adox treatments were performed as previously 
described [10]. For the Western blots, polyvinylidene difluoride (PVDF) 
membranes were probed with the antibodies rabbit polyclonal anti-GFP (Abcam) 
and monoclonal anti 5xHis (Qiagen). Horseradish peroxidase-conjugated 
secondary antibodies (Sigma) and the reagent luminol (Santa Cruz 
Biotechnology) were used to detect the primary antibodies. For the 
immunoprecipitations, cells were lyzed in a non-denaturing NP-40 lysis buffer 
(20 mM Tris-HCl, pH 7.4; 150 mM NaCl; 1 mM EDTA; 1 mM phenyl-
methylsulfonil fluoride; 1% NP-40) under constant homogenization. Protein-G 
Sepharose beads (Amersham Biosciences) and monoclonal antibodies against 
PRMT1 (Abcam) or against mono- or di-methylated (anti-R-methyl) arginines 
(Sigma) were used to immunoprecipitate the protein complexes. 
 
Microscopic analyses 
HEK-293-transfected cells growing on glass coverslips were fixed with PBS 
containing 2% paraformaldehyde, permeabilized with 0.3% of Triton X-100, and 
blocked with PBS/2% BSA. The primary antibodies (anti-SC-35 or anti-
nucleophosmin/B23, both monoclonal antibodies from SIGMA) were incubated 
at room temperature in PBS/2% BSA followed by incubation with the Alexa594-
coupled secondary antibodies (Invitrogen). The coverslips were mounted with 
Prolong® gold antifade medium containing DAPI (Invitrogen). The cells were 
examined with either a Nikon fluorescence microscope or a Leica TCS SP5 laser 
scanning confocal microscope (Leica Microsystems). The latter was used for the 
co-localization assays. For the quantitative phenotypic analysis, three 
independent slides were examined by fluorescence microscopy for the presence 
of nuclear dots upon treatment with Adox, an inhibitor of methylation.  
A hundred cells were counted on each microscopic slide across randomly chosen 




Amino acid sequence analysis of the human SR protein family reveals the 
presence of several RG-rich motifs  
We analyzed the amino acid sequences of various known SR protein family 
members looking for the presence of RG-rich clusters that might function as 
putative targets for arginine methylation. We found several regions containing 
RGG, RG or RXR motifs in all of the analyzed sequences (Fig. 1). 





Fig. 1. The protein sequence alignment of the SR protein family members. The comparisons 
were performed using the ClustalW software [26]. The amino acid sequences of the human 
proteins were: hsSFRS1/SF2_isoform1 (NP_008855.1), hsSFRS1/SF2_isoform2 
(NP_001071634.1), hsSFRS9/SRp30c (NP_003760.1), hsSFRS4/SRp75 (NP_005617.2), 
hsSFRS6/SRp55 (NP_006266.2), hsSFRS5/SRp40 (NP_008856.2), hsSFRS2/SC35 
(NP_003007.2), hsSFRS2B/SRp46 (NP_115285.1), hsSFRS3/SRp20 (NP_003008.1), and 
hsSFRS7/9G8 (NP_001026854.1). RG-rich clusters (RG or RGG or RXR) are indicated in 
red. As predicted by the SMART tool [7], those amino acids belonging to the RRM or RS 
domains are respectively highlighted in grey and blue.  
 
The alignment analysis revealed that there is not necessarily a conservation of 
the localization of RG-rich clusters among the sequences. Where it exists, it is 
restricted to those sequences that are more closely related. Moreover, we did not 
observe a pattern for the distribution of the RG-rich motifs across the sequences 
and domains (RRM or RS domains). This indicates that arginine methylation 
may occur in different regions of the SR proteins’ primary structures. Therefore, 
if most of these RG-rich clusters are methylated in vivo, they might control the 
different functions of the two types of domain. Despite these sequence 
signatures, to date no SR proteins have been studied in detail with respect to 
their arginine methylation and its consequences. There is only indirect evidence, 
principally revealed by proteome studies performed using different antibodies 
against dimethylated peptides [5]. This approach identified many  SR proteins 
that have been considered putative new epitopes for arginine methylation or 
splicing factors that were identified due to co-purification with methylated 




snRNP proteins [5]. Indeed, several spliceosomal components and splicing 
factors have been shown to be methylated, indicating that the splicing activity is 
under the control of arginine methylation [11], and supporting the hypothesis 
that SR proteins might also be arginine methylated. 
 
Arginine methylation analysis of SFRS9 
In our earlier yeast two-hybrid studies, we found that SFRS9 is an interacting 
partner of the protein Ki-1/57  (unpublished observation). Although SFRS9 has 
not yet been directly linked to arginine methylation processes, Ki-1/57 and 
several other RNA-binding proteins that we found to interact with it have 
already been described to be methylated by the arginino methyl transferase 
PRMT1 [8], suggesting a common functional context shared by these proteins 
which may be under the control of arginine methylation. Moreover, when we 
approached the yeast two-hybrid system to find new protein substrates for 
PRMT1, we found SFRS1 [8], an SR protein highly similar to SFRS9 with 
regard to its amino acid sequence (SFRS1-isoform1 versus SFRS9: 72.9% 
sequence identity and 88.2% similarity). Interestingly, SFRS1 binds SF2p32 
[12], another protein that we found to be an Ki-1/57 interacting partner in our 
yeast two-hybrid analysis [13]. Therefore, our protein-protein interaction data 
strongly suggests that SFRS9 would also be a target for arginine methylation. 
The MEMO software predicted that most of the RG-clusters of the SFRS9 
amino acid sequence would be methylated (Fig. 2A). To obtain information on 
the methylation status of SFRS9 in HEK-293 cells, we expressed it as an EGFP-
fused protein and performed immunoprecipitation assays using antibodies that 
recognize both mono- and dimethylated arginines. We mainly detected EGFP-
SFRS9 in the immunoprecipitates obtained from the lysates of the control cells, 
and, to a much lesser extent, in cells that had been treated with the methylation 
inhibitor Adox (Fig. 2B), suggesting that EGFP-SFRS9 is methylated in vivo or 
is associated with arginine-methylated complexes in HEK-293 cells.  
We also verified if EGFP-SFRS9 would be associated with PRMT1 in vivo 
through immunoprecipitation experiments. We were able to demonstrate this 
association (Fig. 2C), thereby giving further support to the hypothesis of  
a functional association between SFRS9 and PRMT1. As immunoprecipitation 
assays may also involve indirect associations, we next assessed if SFRS9 could 
also be a direct target for arginine methylation in vitro. Using a catalytically active 
recombinant GST-PRMT1, we observed the methylation of the baculovirus-
derived recombinant 6xHisSFRS9 (Fig. 2D). The methylation was highly specific, 
since neither an unrelated recombinant protein (FEZ1) nor any protein from a cell 
lysate of insect cells infected with the wild type baculo virus showed any 
radioactive labeling (Fig. 2D). Importantly, the PRMT1 was used as a methylating 
enzyme here due to the functional interconnections described above for this 
arginine methyl transferase and the proteins SFRS9, Ki-1/57, SFRS1 and SF2p32. 
This represents only a first approach, as we could not exclude the possibility that 
SFRS9 could be also methylated by other members of the PRMT family in vivo.     
 





Fig. 2. A methylation analysis of SFRS9. A – The presence of RG-rich clusters in the amino 
acid sequence of SFRS9 (bold). The MEMO software predicted that the underlined arginines 
(R) would be methylated [27]. B – Immunoprecipitation with anti-R-methyl antibodies. 
Before the immunoprecipitation, an aliquot of each whole cell lysate was obtained to monitor 
the EGFP-SFRS9 expression levels in HEK-293-transfected cells (upper panel). Black 
arrowheads denote the detection of EGFP-SFRS9 fusion protein. C – The association of 
EGFP-SFRS9 with the endogenous PRMT1. Lysates of HEK-293 cells transfected with 
EGFP (negative control) or EGFP-SFRS9 were subjected to immunoprecipitation assays 
using a monoclonal antibody against the arginino-mehyltransferase PRMT1 (lower panels). 
Endogenous PRMT1 or GFP-SFRS9 were detected by Western blot. An aliquot of each 
whole cell lysate was also obtained to monitor the levels of EGFP or EGFP-SFRS9 (upper 
panel). Black arrowhead: EGFP-SFRS9; black arrow: EGFP; white arrowhead: PRMT1.  
D – The SFRS9 is a substrate for PRMT1 methylation in vitro. The purified GST-PRMT1 
was incubated in the presence of the 3H-radiolabeled methly-donor SAM with purified 6xhis-
FEZ1 (unrelated control protein [28]), or a lysate of Sf9 insect cells infected with a wild type 
baculovirus (BV; negative control), or a lysate of Sf9 insect cells infected with a 6xHis-
SFRS9 recombinant baculovirus. The left panel shows the resulting autoradiography.  
A Coomassie Blue gel (middle) revealed equal loading with the lysate, and a Western blot 
(right) assay showed the presence of the recombinant proteins.  




The inhibition of methylation by Adox causes the re-localization of EGFP-
SFRS9  
In previous fluorescence microscopy studies, we found that the nuclear and 
cytoplasmic protein Ki-1/57 predominantly re-localizes to the nucleus, where it 
accumulates as discrete, dot-like substructures upon the inhibition of 
methylation [8]. We therefore reasoned that a similar re-distribution may also be 
found for SFRS9. Indeed, we observed that when methylation is inhibited by 
Adox in human HEK-293 cells, a great proportion of EGFP-SFRS9 localizes to 
several nuclear dots (Fig. 3A). We found that more than 90% of the analyzed 
cells presented such substructures (Fig. 3D). Moreover, we found such dot-like 
structures even in control cells, but in this case, the observed bodies constituted 
fainter structures, being found in only around 29% of the counted cells 
(subpopulation 1) (Fig. 3B and D). The remaining transfected cells (around 71%; 
subpopulation 2) present a predominantly diffuse EGFP-SFRS9 nuclear 
distribution, without any observable granules (Fig. 3C and D). These findings 
suggest that SFRS9 is not only a target for arginine methylation, but that this 
activity is also important for its localization and trafficking in mammalian cell 
nuclei.  It has been shown that arginine methylation can influence the subcellular 
localization of a number of RNA-binding proteins [9, 14], which is in close 
agreement with our observations for this member of the SR protein family. 
 
The EGFP-SFRS9 can co-localize to the nucleoli in HEK-293 cells treated 
with Adox  
It is already known that SFRS9 and many other SR-proteins localize to splicing 
speckles [15]. These nuclear dot-like substructures are functionally associated with 
pre-mRNA splicing, and their composition and localization in the cell nucleus is 
highly dynamic, being influenced by several conditions such as heat shock 
treatment and drug-mediated inhibition of protein dephosphorylation or 
transcription [16, 17]. In order to verify if the inhibition of methylation can also 
affect the structure of speckles or the localization of EGFP-SFRS9 into this 
organelle, we performed co-localization experiments of EGFP-SFRS9 with the 
speckle marker protein SC-35, another member of the SR-protein family.  
Through confocal microscopy analyses, we observed that in untreated control 
cells, the EGFP-SFRS9 was principally diffuse in the nucleoplasm, although there 
was some weak and partial co-localization with SC-35 splicing speckles (Fig. 4A, 
1-3). We did not find any apparent changes in the distribution and overall structure 
of the speckles in cells submitted to Adox treatment, suggesting that this 
compartment may not suffer structural modifications under such conditions  
(Fig. 4A, compare panels 2 and 5). Also, this treatment did not seem to cause any 
detectable modifications in the partial association between EGFP-SFRS9 and this 
nuclear substructure (Fig. 4A, 1-3 and 4-6). On the other hand, upon confocal 
analysis, the previously observed EGFP-SFRS9-associated bodies appeared as 
structures that resemble different juxtaposed rings in regions possibly related to 
the nucleoli (Fig. 4A, white arrows in the insets of the panels 4 and 6). 





Fig. 3. The localization of EGFP-SFRS9 in cells with inhibited methylation.  
A-C – Fluorescence microscopy analyses of human HEK-293 cells expressing the 
construct EGFP-SFRS9, and either treated with Adox or untreated. Nuclear DNA labeled 
with DAPI is shown in blue. D – The proportion of HEK-293 cells transfected with EGFP-
SFRS9 displaying nuclear bodies. A hundred cells were counted across randomly choosen 
fields in each of three independent slides analyzed for each condition (n = 3): Adox-treated 
cells or untreated control cells (a total of 600 events/transfected cells counted). Two 
different subpopulations of cells were found in the control slides. They are marked as 
phenotype  1 (with the presence of granules, normally discrete, shown as subpopulation 1 
in B) or phenotype 2 (without granules, shown as subpopulation 2 in C).    
 






Fig. 4. Confocal analysis of EGFP-SFRS9 in the splicing speckles and nucleoli. A – Co-
localization of EGFP-SFRS9 to the splicing speckles (SC-35). Selected regions in panels 
4-6 are shown as separated figure insets (i, ii, and iii). White arrowheads show regions of 
partial co-localization between EGFP-SFRS9 and the speckles, while white arrows indicate 
the ring-like structures formed upon Adox treatment. B – Co-localization of EGFP-SFRS9 
to the nucleoli (Nucleophosmin, NPM). C – A selected region of image 6 is shown in detail 
as separated insets. The arrows show EGFP-SFRS9 localization (green) in the outer 
subregions of the nucleolar space delimited by nucleophosmin (red). D – Confocal laser 
microscopic sections taken 0.3 µm apart reveal that EGFP-SFRS9 can be also found 
(green) in the inner subregion of nucleoli (arrowheads). Scale bar, 3 µm. Arrows show 
EGFP-SFRS9 substructures in the more external nucleolar subregion.   
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Thereafter, aiming to test if such EGFP-SFRS9-associated substructures localize 
to the nucleolar region upon Adox treatment, we analyzed the co-localization of 
EGFP-SFRS9 with the marker protein nucleophosmin/B23. Overall, we observed 
that EGFP-SFRS9 in the control cells localized to the whole nucleoplasm with the 
exception of the nucleoli, from which it is excluded in most of the analyzed cases 
(Fig. 4B, 1-3). However, upon the inhibition of methylation, we observed that 
EGFP-SFRS9-associated bodies localized inside of the region delimited by 
nucleophosmin (Fig. 4B, 4-6) at different nucleolar subregions: more externally 
and, curiously, also more internally (selected regions in Fig. 4B, 6 and insets in 
Fig. 4C, i1-i3). The nucleolus is known to be constituted by distinct internal 
subregions which are involved in different stages of ribosome biogenesis or other 
more speculative functions [18]. To gain further insight into the localization of 
EGFP-SFRS9 in the inner nucleolar region, we obtained images at different planes 
of the cell (Fig. 4B). We verified that EGFP-SFRS9 seems to have a disposition in 
the shape of a tube inside the nucleolus (Fig. 4D, j1-j5). Moreover, depending on 
the image planes analyzed, the localization of the EGFP-SFRS9 substructure could 
also be observed in the outer nucleolar region, coexisting with the central structure 
in the same analyzed nucleolus (Fig. 4D, j1,  j2). Together, these observations 
suggest that SFRS9 might be involved in different steps of the maturation of 





The nucleoli are primarily involved in ribosome biogenesis in eukaryotic cells. 
However, several lines of evidence point to a more complex and multifunctional 
role for this nuclear organelle [18]. As with the maturation of rRNA, later steps 
in snRNA maturation require several snoRNA-guided modifications as 2’-O-ribose 
methylation and pseudouridination [18, 19]. It has been reported that before 
reaching the nuclear speckles, snRNAs pass through the nucleoli and undergo 
such modifications [20, 21]. SFRS9 may be part of these maturation complexes, 
and its release from the nucleoli to the nucleoplasm may be under the control of 
arginine methylation. Independently of the involvement of SFRS9 in ribosomal 
biogenesis or snRNA maturation, our observations raise new questions on the 
function of this SR protein. Several proteome studies have identified more than 
700 human proteins that co-purify with isolated nucleoli. The functional 
classification of these proteins surprisingly revealed that only 30% of them are 
related to the production of ribosome subunits. The other fraction reveals the 
additional processes that may occur within these structures. It includes factors 
involved in splicing/pre-mRNA processing, cell-cycle control, and DNA 
replication and repair [18]. These observations indicate that the localization of  
a splicing factor like SFRS9 inside the nucleolar region may not be an artifact 
resulting from over-expression experiments, but may indeed have functional 
meaning. Besides the nucleolar localization of snRNPs upon okadaic acid 
treatment [16], the link between splicing activity and the nucleolar compartment 




was reinforced by several other reports that show the transient accumulation of 
splicing factors in these nuclear compartments [16, 22, 23]. Moreover, several 
splicing proteins have been identified in such proteomic studies, including 
SFRS9 and other SR proteins [24], in agreement with our observations here. 
Many studies have revealed that various additional components within the 
nucleolus are not constitutive but are rather dynamic components of the 
nucleolus, in such a way that it may have not been possible to detect them using 
the mentioned nucleolar proteome analyses [25]. The observed accumulation of 
SFRS9 within the nucleoli in Adox-treated cells may be a consequence of  
a misbalance in the entry and exit rates in cells under equilibrium conditions. 
The inhibition of methylation may for instance disfavor the nucleolar exit of 
EGFP-SFRS9, which would depend on its arginine methylation. This may be 
reinforced by the observation that around 29% of untreated control cells also 
presented such nucleolar EGFP-SFRS9-associated structures (Fig. 3B and D), 
reflecting a normal equilibrium state between the entrance and exit from the 
nucleoli. In cells subjected to the inhibition of protein dephosphorylation by 
okadaic acid, a similar pattern of localization in the intra-nucleolar compartment 
has been observed for the p80 protein coilin, and for splicing-associated snRNPs 
[16]. Intriguingly, in this case, the same was not observed for the SR protein SC-35 
in these treated cells [16]. That in our experiments with EGFP-SFRS9 in Adox-
treated cells, we could not observe SC-35 in the nucleolus suggests not only the 
selectivity of Adox treatment, but also that these two SR proteins are involved in 
slightly different functional mechanisms which may be physically separated by 
nuclear sub-compartmentalization. 
In conclusion, we described here for the first time the arginine methylation of  
a SR-protein family member, SFRS9, and demonstrated how this post-
translational modification may affect its subnuclear localization. Future 
experiments will address the functional significance of the association of SFRS9 
to the nucleolar compartment, and the details of this important post-translational 
modification for it and possibly other SR proteins. 
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